SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
                  （深 圳 市 海 普 瑞 藥 業 集 團 股 份 有 限 公 司）

                                                9989




             OREGOVOMAB 3



 2020 11 10       OncoQuest Pharmaceuticals Inc.      Dual Industrial Co., Ltd.
   KOSDAQ                         078590.KQ      OncoQuest Pharmaceuticals
 OncoQuest Pharma USA, Inc.                          Oregovomab 3
                                                              17        140
   602

    FLORA-5   3
Oregovomab




FLORA-5            Gynecologic Oncology Group Foundation     IQVIA

Oregovomab

                      OncoQuest Inc.                                    37.8%
     OncoQuest Inc. OncoQuest Pharmaceuticals                    OncoQuest Inc.
                                                OncoQuest Inc.
       OncoQuest Pharmaceuticals   50.7%




                                           1
OREGOVOMAB

Oregovomab               CA 125                     IgG                             97
    2                             Oregovomab
                                           2                Oregovomab
                                          2                        PFS 41.8
        12.2          3.5                                              Oregovomab
                                       50%                              Oregovomab
                          Oregovomab                        Gynecology Oncology (2020
156:523-529) Cancer Immunology and Immunotherapy (2020 69:383-397)

ONCOQUEST PHARMACEUTICALS

OncoQuest Pharmaceuticals
    OncoQuest Pharmaceuticals                                    CA-125   MUC1 PSA       Her2/
neu                                                                       2020 4
             OncoQuest Inc.           OncoQuest Pharmaceuticals



OncoQuest Pharmaceuticals                      Oregovomab             CA-125
                                        3
                     2                             OncoQuest Pharmaceuticals       MUC1
                               1                                                     OncoVent
Co. Ltd.           OncoQuest Pharmaceuticals
                     Advanced Immune Therapeutics, Inc.                        E
                 IgE




2020   11   10




                                               2